Maternal endothelial dysfunction and its association with abnormal fetal growth in diabetic pregnancy

Diabetic Medicine

Volumn 28, Issue 6, 2011, Pages 692-698

  Zawiejska, A ^a   Wender Ozegowska, E ^a   Pietryga, M ^a   Brazert, J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Diabetes; Fetal growth; Pregnancy; SE selectin; SVCAM 1

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; HUMAN INSULIN; INSULIN DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BIRTH WEIGHT; DIABETIC DIET; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FETUS GROWTH; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; VASCULAR ENDOTHELIUM;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY IN DIABETICS;

EID: 79955966795     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03249.x     Document Type: Article

References (30)

1. Lepercq J, Taupin P, Dubois-Lafourgue D, Duranteau L, Lahlou N, Boitard C et al. Heterogeneity of fetal growth in type1 diabetic pregnancy. Diabetes Metab 2001; 27: 339-344.
2. Dunne FP. Pregestational diabetes mellitus and pregnancy. Trends Endocrinol Metab 1999; 10: 179-182.
3. Star J, Carpenter MW. The effect of pregnancy on the natural history of diabetic retinopathy and nephropathy. Clin Perinatol 1998; 25: 887-915.
4. Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type1 diabetes. Diabet Med 2001; 18: 573-577.
5. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial. Diabetes Care 2000; 23: 1084-1091.
6. Kyne-Grzebalski D, Wood L, Marshall SM, Taylor R. Episodic hyperglycaemia in pregnant women with well-controlled Type1 diabetes mellitus: a major potential factor underlying macrosomia. Diabet Med 1999; 16: 702-706.
7. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992.
8. Mueller MM, Griesmacher A. Markers of endothelial dysfunction. Clin Chem Lab Med 2000; 38: 77-85.
9. Sumpio BE, Riley T, Dardik A. Molecules in focus. Cells in focus: endotheliall cell. Int J Biochem Cell Biol 2002; 34: 1508-1512.
10. Stehouwer CDA, Lambert J, Donker AJM, Hinsbergh VWM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34: 55-68.
11. Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit 2001; 7: 1075-1085.
12. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11: 767-804.
13. Baumgartner-Parzer SM, Waldhaeusl WK. The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. Exp Clin Endocrinol Diabetes 2001; 109: S166-S179.
14. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4313-4317.
15. Zozulińska D, Majchrzak A, Markiewicz S, Wierusz-Wysocka B. Selected markers of inflammatory response in diabetic patients. Diabetes Res 1996; 31: 33-39.
16. Zozulińska D, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B. Levels of serum cell adhesion molecules in type1 diabetic patients with microangiopathy. Diabetologia 1999; 42: A319.
17. Zozulińska D, Wierusz-Wysocka B. Role of neutrophils in pathogenesis of chronic diabetes complications. Diabet Prakt 2004; 5: 139-142.
18. Ang C, Hillier C, Cameron AD, Greer IA, Lumsden MA. The effect of type1 diabetes mellitus on vascular responses to endothelin-1 in pregnant women. J Clin Endocrinol Metab 2001; 86: 4939-4942.
19. Briese V, Kunkel S, Rohde E, Friese K. Endothellaesionen in der Schwangerschaft - Nachweis von Adhaesionsmolekuelen (sVCAM-1) im Serum (Endothelial lesions in pregnancy - detection of serum adhesion molecules (sVCAM-1)). Zentralbl Gynakol 1999; 121: 196-197.
20. Raynor BD, Parthasarathy S. Maternal serum vascular cell adhesion molecule concentration during pregnancy. J Soc Gynecol Invest 1997; 4: 78-80.
21. Malewski Z, Słomko Z, Klejewski A. Relationship between gestational age and birthweight from Poznan region. Kliniczna Perinatologia i Ginekologia 1995; 12: 734-741.
22. Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Mater Fetal Med 2000; 9: 35-41.
23. Mitkowska-Woźniak H, Bra{ogonek}zert J, Wender-Ożegowska E, Meissner W, Persona-Śliwinska A, Pietryga M et al. Prediction of fetal macrosomia using sonographically measured abdominal subcutaneous tissue thickness in pregnancies complicated by diabetes mellitus. Ginekol Pol 2003; 74: 1444-1449.
24. Zawiejska A, Wender-Ożegowska E, Mitkowska H, Pietryga M, Bra{ogonek}zert J. Factors influencing birthweight in diabetic pregnancy. Arch Perinat Med 2004; 10: 37-41.
25. Peterson CM, Jovanovic-Peterson L, Mills JL, Conley MR, Knopp RH, Reed GF et al. The Diabetes in Early Pregnancy Study: changes in cholesterol, triglycerides, body weight, and blood pressure. Am J Obstet Gynecol 1992; 166: 513-518.
26. Zygmunt M, Boving B, WIenhard J, Munstedt K, Braems G, Bohle RM et al. Expression of cell adhesion molecules in the extravillous trophoblast is altered in IUGR. Am J Reprod Immunol 1997; 38: 295-301.
27. Reece EA, Sivan E, Francis G, Homko CJ. Pregnancy outcomes among women with and without diabetic microvascular disease (White's classes B to FR) versus non-diabetic controls. Am J Perinatol 1998; 15: 549-555.
28. Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 2001; 24: 1904-1910.
29. Dworacka M, Wender-Ozegowska E, Winiarska H, Borowska M, Zawiejska A, Pietryga M et al. Plasma anhydro-D-glucitol (1, 5-AG) as an indicator of hyperglycaemic excursions in pregnant women with diabetes. Diabet Med 2006; 23: 171-175.
30. Catalano PM, Kirwan JP, Haguel-de Mouzon S, King J. Gestational diabetes and insulin resistance:role in short- and long-term implications for mother and fetus. J Nutr 2003; 133: 1674S-1683S.